J. Armand Bombardier Foundation donates $200 000 to advance prostate cancer research

NewsGuard 100/100 Score

Concerned with the health and well being of Canadians, the J. Armand Bombardier Foundation has donated $200 000 to the PROCURE Quebec Prostate Cancer Biobank, a tool to accelerate the pace of research on prostate cancer.

"The well-being of individuals and innovation are the focus of the J. Armand Bombardier Foundation in the area of health. The Biobank developed by PROCURE enables research that will contribute to better healthcare for patients; the PROCURE Biobank is a partner of choice for the Foundation", notes Madame Lyne Lavoie, Director General of the J. Armand Bombardier Foundation.

Prostate cancer is the most common type of cancer among Canadian men. One in seven men will develop the disease during his lifetime. As Jack Layton, leader of the New Democratic Party of Canada announced last Friday, "This year, more than 25,000 Canadian men will be diagnosed with treatable prostate cancer and I have recently learned that I'm one of them".

The PROCURE Quebec Prostate Cancer Biobank was created in order to help men touched by prostate cancer and their families. It is a critically important research tool for prostate cancer in Quebec. By collecting and storing a large amount of biological samples and clinical, medical and sociological data from men with prostate cancer, scientists will be better able to identify risk factors, improve detection methods, optimize treatments, and help prevent prostate cancer.

The Biobank collection takes place within four major University Health Centers in the province of Québec : the University of Montreal Hospital Center (CHUM), the Centre Hospitalier Universitaire de Québec (CHUQ), the McGill University Health Center (MUHC) and the Centre Hospitalier Universitaire de Sherbrooke (CHUS).

"Without the synergy and the support of partners such as the J. Armand Bombardier Foundation, a project of this magnitude could never have been possible" comments Malvina Klag, PROCURE's Executive Director.

Source: PROCURE

Source:

J. ARMAND BOMBARDIER FOUNDATION

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis